EP Wealth Advisors LLC Invests $323,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

EP Wealth Advisors LLC purchased a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 1,250 shares of the biotechnology company’s stock, valued at approximately $323,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Virtu Financial LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth $439,000. Cim LLC purchased a new stake in Axon Enterprise during the 4th quarter worth about $1,409,000. V Square Quantitative Management LLC lifted its holdings in Axon Enterprise by 22.1% during the 4th quarter. V Square Quantitative Management LLC now owns 1,750 shares of the biotechnology company’s stock worth $452,000 after purchasing an additional 317 shares in the last quarter. Comerica Bank lifted its holdings in Axon Enterprise by 1.3% during the 4th quarter. Comerica Bank now owns 143,527 shares of the biotechnology company’s stock worth $37,077,000 after purchasing an additional 1,777 shares in the last quarter. Finally, Barometer Capital Management Inc. purchased a new stake in Axon Enterprise during the 4th quarter worth about $1,745,000. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of a number of recent research reports. Argus initiated coverage on Axon Enterprise in a report on Wednesday, March 13th. They set a “buy” rating and a $380.00 price objective on the stock. TheStreet cut Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a report on Thursday, April 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a report on Tuesday, May 7th. Finally, Robert W. Baird raised their price target on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, February 22nd. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $335.27.

Insider Buying and Selling

In related news, Director Julie A. Cullivan sold 993 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the transaction, the director now directly owns 4,553 shares in the company, valued at approximately $1,282,671.16. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, Director Jeri Williams sold 308 shares of Axon Enterprise stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $310.07, for a total value of $95,501.56. Following the sale, the director now directly owns 1,607 shares in the company, valued at approximately $498,282.49. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Julie A. Cullivan sold 993 shares of Axon Enterprise stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $281.72, for a total value of $279,747.96. Following the completion of the sale, the director now owns 4,553 shares in the company, valued at $1,282,671.16. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock worth $27,684,677 in the last ninety days. 5.70% of the stock is owned by insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $293.52 on Thursday. The stock has a market cap of $22.15 billion, a price-to-earnings ratio of 85.82 and a beta of 0.91. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The stock’s 50-day moving average is $296.74 and its 200 day moving average is $282.18.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The company had revenue of $460.74 million for the quarter, compared to analysts’ expectations of $441.57 million. During the same period last year, the firm posted $0.51 EPS. Axon Enterprise’s revenue for the quarter was up 34.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.